Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/29/2010US7745179 Lentiviral producer cell; such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor
06/29/2010US7745176 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation
06/29/2010US7745174 co-expressing two heterotypes of Hepatocyte Growth Factor (HGF) comprising transforming or transfecting to a cell a DNA construct; for prevention and treatment of ischemic and liver disorders
06/29/2010US7745162 Compositions and methods for measuring levels of bioactive human hepcidin
06/29/2010US7745147 use of a monoclonal antibody in the purification of an interferon composition comprising a plurality of interferon alpha subtypes; purification of a crude human leukocyte interferon to greater than 95 percent purity
06/29/2010US7745139 for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension
06/29/2010US7745130 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
06/29/2010US7745126 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
06/29/2010US7745109 Regulation of cell growth by MUC1
06/29/2010US7745066 mixing polyvinyl alcohol, and cellular membrane-free proteorhodopsin in an aqueous solution, solidifying; used as optical data storage material or a fraud-proof carrier; produces a photocyle when exposed to light of excitation wavelength; security ink; easy to produce the protein, expressed in E. coli
06/29/2010US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/29/2010US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
06/29/2010US7744906 Chaperone proteins comprising at least one of three specific nucleotide sequences; analgesics; side effect reduction; lastslonger than narcotics; relieving any type of pain
06/29/2010US7744905 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
06/29/2010US7744903 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination; host cells
06/29/2010US7744902 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
06/29/2010US7744901 A reassortant influenza virus comprises 6 internal genome segments from A/Ann Arbor/6/60 and one genome segment comprising a nucleic acid encoding a hemagglutinin polypeptide comprising the amino acid sequence of SEQ ID NO: 11; live, split or killed vaccine; immunostimulants
06/29/2010US7744898 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
06/29/2010US7744897 Human immunodeficiency virus gp41 mimetibody polypeptides
06/29/2010US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection
06/29/2010US7744894 Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24
06/29/2010US7744892 Optimized expression of HPV 52 L1 in yeast
06/29/2010US7744891 Using lymphotoxin-beta receptors ligand specific immunoglobulin as therapeutic agent in treatment and prevention of lupus and thrombocytopenia
06/29/2010US7744886 Methods for interfering with rank signaling
06/29/2010US7744885 administering antibodies or antigen-binding fragments which are specific for human tumor necrosis factor- alpha (TNF alpha), used for in vivo medical diagnosis and therapy; immunoassay and immunotherapy
06/29/2010US7744881 for cancer treatment by inducing apoptosis; monoclonal antibodies; drug conjugated with polyoxyethylene glycol or enzyme or radioisotope, fluorescent compound or chemiluminescent compound; genetic engineering; biodrugs; anticarcinogenic agents
06/29/2010US7744871 comprising an antibody against an EGF receptor and a vaccine which induces antibodies against EGF or TGF alpha; based on the blockade of receptors with protein kinase activity in tyrosine residues (Receptor Tyrosine Kinases, RTK)
06/29/2010US7744870 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs
06/29/2010US7744862 Propagating and isolating cell growth factors from prokaryotic systems using ion exchange and reverse phase chromatography; bioreactor and heterologous gene expression
06/29/2010US7744853 Radiolabeled annexins
06/29/2010CA2636421C A method of platelet and whole blood storage
06/29/2010CA2428158C Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
06/29/2010CA2417923C Vaccination against host cell-associated herpesviruses
06/29/2010CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
06/29/2010CA2390082C Novel hcv non-structural polypeptide
06/29/2010CA2370477C Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
06/29/2010CA2370225C Highly purified gonadotropin compositions and process for preparing them
06/29/2010CA2360053C Plant gene
06/29/2010CA2358439C Metastasis models using green fluorescent protein (gfp) as a marker
06/29/2010CA2337969C Compound and method for the prevention and/or the treatment of allergy
06/29/2010CA2326374C Process for the recovery and purification of a recombinant protein from a cell
06/29/2010CA2326373C Methods and substances for preventing and treating autoimmune disease
06/29/2010CA2325345C Medicaments for inducing cytotoxic t-cells
06/29/2010CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/29/2010CA2286795C Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
06/29/2010CA2274498C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/29/2010CA2252372C Pathogenic escherichia coli associated protein
06/29/2010CA2251560C Pesticidal toxins
06/29/2010CA2236700C Immunity against pasteurella haemolytica leukotoxin
06/29/2010CA2218364C Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
06/29/2010CA2195169C Transfection competent molecules
06/29/2010CA2187740C Dna encoding bradykinin b1 receptor
06/29/2010CA2187346C Receptor modulating agents and methods relating thereto
06/29/2010CA2134030C Soluble interferon .alpha.-receptor, its preparation and use
06/24/2010WO2010071897A2 Engineering heat-stable disease resistance in plants
06/24/2010WO2010071190A1 Heparin affinity erythropoietin
06/24/2010WO2010070968A1 Gene coding for protein having the ability to enhance selenic acid reduction activity
06/24/2010WO2010070877A1 Elovl7 epitope peptides and vaccines containing the same
06/24/2010WO2010070581A1 Method and device for diagnosing tuberculosis
06/24/2010WO2010070380A2 Doc1 compositions and methods for treating cancer
06/24/2010WO2010070255A1 Glucagon analogues
06/24/2010WO2010070253A1 Glucagon analogues
06/24/2010WO2010070252A1 Glucagon analogues
06/24/2010WO2010070251A1 Glucagon analogues
06/24/2010WO2010070136A2 Novel caviidae allergens and uses thereof
06/24/2010WO2010070098A1 High growth reassortant influenza a virus
06/24/2010WO2010070052A2 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
06/24/2010WO2010070047A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
06/24/2010WO2010069950A1 Bidirectional promoter from z. mais
06/24/2010WO2010069946A1 Purification of factor v
06/24/2010WO2010069914A1 Statin transcription regulators
06/24/2010WO2010069847A1 Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same
06/24/2010WO2010069771A1 Method for extracting hydrophobin from a solution
06/24/2010WO2010069570A2 Peptides against autoantibodies associated with crps and use of these peptides
06/24/2010WO2010069074A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
06/24/2010WO2010046592A3 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies
06/24/2010WO2010046588A9 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
06/24/2010WO2010043972A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
06/24/2010WO2010043444A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
06/24/2010WO2010042530A3 Nlrc5 as a target for immune therapy
06/24/2010WO2010034514A9 Novel regulators of the innate immune system
06/24/2010WO2010030840A3 Novel receptor and uses thereof
06/24/2010WO2010021738A3 Method for producing double-crosslinked collagen
06/24/2010WO2010011952A3 Flip death effector domain derived peptides for inducing autophagy
06/24/2010WO2010006772A3 Use of cd95 inhibitors for the treatment of inflammatory disorders
06/24/2010WO2009158618A4 Avian reoviridae
06/24/2010WO2009148964A3 Expression and assembly of human group c rotavirus-like particles and uses thereof
06/24/2010WO2009068564A8 Plants having enhanced yield-related traits and a method for making the same
06/24/2010US20100162444 Nucleic Acid molecules and other molecules associated with plants
06/24/2010US20100162443 Promoters for regulation of gene expression in plant roots
06/24/2010US20100162441 Plants Having Improved Growth Characteristics And Method For Making The Same
06/24/2010US20100162439 Pesticidal genes from brevibacillus and methods for their use
06/24/2010US20100162437 Functional r-gene from solanum bulbocastanum
06/24/2010US20100162421 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
06/24/2010US20100162418 Recombinant protein s composition
06/24/2010US20100162415 Transgenic mice expressing humanized vegf
06/24/2010US20100160612 Muteins of tear lipocalin with affinity for the t-cell coreceptor cd4
06/24/2010US20100160611 Human skeletal muscle-specific ubiquitin-conjugating enzyme
06/24/2010US20100160610 Conjugates of an EPO Moiety and a Polymer
06/24/2010US20100160609 Chimera Botulinum Toxin Type E
1 ... 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 ... 2916